GKSL vs EMUDHRA: Stock Comparison
Head-to-head financial and trading comparison between Gujarat Kidney And Super Speciality Limited (GKSL) and eMudhra Limited (EMUDHRA) in the Cross-Sector Peers sector.
GKSL
NSE: GKSLEMUDHRA
NSE: EMUDHRAKey Metrics Comparison Table
| Metric | GKSL | EMUDHRA | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹184.09 | ₹570.15 | — |
| 1-Year Price Return | +63.49% | +13.78% | GKSL (49.71% higher) |
| 52-Week High | ₹194.27 | ₹662.00 | — |
| 52-Week Low | ₹110.40 | ₹432.30 | — |
| 30-Day Annualized Volatility | 44.2% | 77.89% | GKSL (Steadier) |
| 30-Day Average Daily Volume | 2,108,623 | 1,652,344 | GKSL (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between GKSL and EMUDHRA, which stock gave better returns over the last year?
GKSL has outperformed EMUDHRA over the past 12 months with a gain of 63.49% compared to 13.78%.
Which stock is less volatile: GKSL or EMUDHRA?
GKSL demonstrated lower price volatility (44.2% annualized) compared to EMUDHRA (77.89%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of GKSL vs EMUDHRA?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are GKSL and EMUDHRA direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.